Neutrophil Extracellular Traps Modulate Recruitment and Immunosuppression of Macrophages in Pancreatic Adenocarcinoma.

IF 8.2 1区 医学 Q1 IMMUNOLOGY
Hillary G Pratt, Alyson M Stevens, Michael Sestito, Mercy Ojetunde, Abby D Ivey, Nicole E Mihalik, Kayla J Steinberger, Britney Niemann, E Hannah Hoblitzell, Edwin Wan, Timothy D Eubank, Brian A Boone
{"title":"Neutrophil Extracellular Traps Modulate Recruitment and Immunosuppression of Macrophages in Pancreatic Adenocarcinoma.","authors":"Hillary G Pratt, Alyson M Stevens, Michael Sestito, Mercy Ojetunde, Abby D Ivey, Nicole E Mihalik, Kayla J Steinberger, Britney Niemann, E Hannah Hoblitzell, Edwin Wan, Timothy D Eubank, Brian A Boone","doi":"10.1158/2326-6066.CIR-24-0534","DOIUrl":null,"url":null,"abstract":"<p><p>Pancreatic adenocarcinoma (PDAC) has a dismal survival rate due to limited effective therapies. While studies have focused on innate immune cell influence on adaptive immune cell functions, few have explored interactions between innate immune cells, which modulate the unique PDAC tumor microenvironment (TME). Macrophages are responsible for clearance of neutrophil-mediated inflammation in physiologic immune responses; however, these cells co-exist in PDAC. We sought to determine how neutrophil extracellular traps (NETs), neutrophil release of decondensed chromatin and intracellular contents, affect monocyte/macrophage populations in the PDAC TME. Utilizing samples from patients with PDAC, we demonstrate elevated monocyte chemokine CCL2 in plasma and elevated NET CitH3 and pan-macrophage marker CD68 in the PDAC TME via fluorescent immunohistochemistry. To determine how NETs impacted macrophage populations in the PDAC TME, we depleted NETs with DNase I and with genetic knockout of the PAD4 enzyme and found an elevation in pan-macrophage marker F4/80. The depletion led to increased T cell stimulatory signal CD80 while the pro-tumor macrophage marker CD206 was decreased. We further demonstrate that macrophages in the NET-deficient PDAC TME may be recruited through the CCL2/CCR2 axis, in which CCL2 can be released from tumor cells and macrophages in the presence of IFN-. Taken together, our findings reveal that inhibition of NETs can prime the innate immune response toward an anti-tumor phenotype.</p>","PeriodicalId":9474,"journal":{"name":"Cancer immunology research","volume":" ","pages":""},"PeriodicalIF":8.2000,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer immunology research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1158/2326-6066.CIR-24-0534","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Pancreatic adenocarcinoma (PDAC) has a dismal survival rate due to limited effective therapies. While studies have focused on innate immune cell influence on adaptive immune cell functions, few have explored interactions between innate immune cells, which modulate the unique PDAC tumor microenvironment (TME). Macrophages are responsible for clearance of neutrophil-mediated inflammation in physiologic immune responses; however, these cells co-exist in PDAC. We sought to determine how neutrophil extracellular traps (NETs), neutrophil release of decondensed chromatin and intracellular contents, affect monocyte/macrophage populations in the PDAC TME. Utilizing samples from patients with PDAC, we demonstrate elevated monocyte chemokine CCL2 in plasma and elevated NET CitH3 and pan-macrophage marker CD68 in the PDAC TME via fluorescent immunohistochemistry. To determine how NETs impacted macrophage populations in the PDAC TME, we depleted NETs with DNase I and with genetic knockout of the PAD4 enzyme and found an elevation in pan-macrophage marker F4/80. The depletion led to increased T cell stimulatory signal CD80 while the pro-tumor macrophage marker CD206 was decreased. We further demonstrate that macrophages in the NET-deficient PDAC TME may be recruited through the CCL2/CCR2 axis, in which CCL2 can be released from tumor cells and macrophages in the presence of IFN-. Taken together, our findings reveal that inhibition of NETs can prime the innate immune response toward an anti-tumor phenotype.

中性粒细胞胞外陷阱调节胰腺腺癌中巨噬细胞的募集和免疫抑制。
由于有效的治疗方法有限,胰腺腺癌(PDAC)的生存率很低。虽然研究主要集中在先天免疫细胞对适应性免疫细胞功能的影响,但很少有研究探讨先天免疫细胞之间的相互作用,这种相互作用调节了独特的PDAC肿瘤微环境(TME)。巨噬细胞在生理性免疫反应中负责清除中性粒细胞介导的炎症;然而,这些细胞在PDAC中共存。我们试图确定中性粒细胞胞外陷阱(NETs)、去致密染色质的中性粒细胞释放和细胞内含量如何影响PDAC TME中的单核细胞/巨噬细胞群。利用PDAC患者的样本,我们通过荧光免疫组织化学证明PDAC TME中单核细胞趋化因子CCL2升高,NET CitH3和泛巨噬细胞标志物CD68升高。为了确定NETs如何影响PDAC TME中的巨噬细胞群,我们用DNase I和基因敲除PAD4酶来消耗NETs,发现泛巨噬细胞标志物F4/80升高。这种缺失导致T细胞刺激信号CD80增加,而促肿瘤巨噬细胞标志物CD206减少。我们进一步证明,net缺陷PDAC TME中的巨噬细胞可能通过CCL2/CCR2轴募集,其中CCL2可以在IFN-存在下从肿瘤细胞和巨噬细胞中释放出来。综上所述,我们的研究结果表明,抑制NETs可以启动抗肿瘤表型的先天免疫反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer immunology research
Cancer immunology research ONCOLOGY-IMMUNOLOGY
CiteScore
15.60
自引率
1.00%
发文量
260
期刊介绍: Cancer Immunology Research publishes exceptional original articles showcasing significant breakthroughs across the spectrum of cancer immunology. From fundamental inquiries into host-tumor interactions to developmental therapeutics, early translational studies, and comprehensive analyses of late-stage clinical trials, the journal provides a comprehensive view of the discipline. In addition to original research, the journal features reviews and opinion pieces of broad significance, fostering cross-disciplinary collaboration within the cancer research community. Serving as a premier resource for immunology knowledge in cancer research, the journal drives deeper insights into the host-tumor relationship, potent cancer treatments, and enhanced clinical outcomes. Key areas of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and insightful clinical investigations with immunological implications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信